Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Contact Us

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Dr. Reddy's Laboratories Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	500124
ISIN Demat	INE089A01031
Book Value	377.57

NSE Code	DRREDDY
Dividend Yield %	0.63
Market Cap	1064183.75

P/E	19.71
EPS	64.68
Face Value	1


	BSE		NSE

05-Dec-2025

Last Price	1275.05
Net Change	-1.95
% Change	-0.15%
Prev.Close	1277.00
Open	1277.00
High	1282.70
Low	1271.95
Volume	164697

Last Price	1275.20
Net Change	-2.4
% Change	-0.19%
Prev.Close	1277.60
Open	1277.60
High	1282.80
Low	1271.60
Volume	1036082

Value	210506042
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1282.70
52-Week High	1404.60
52-Week Low	1025.90

Value	1323703363.5
Best Buy	1275.20
Best Sell	0.00
Best Quantity	246
Sell Quantity	0
Today's Range	1282.80
52-Week High	1405.90
52-Week Low	1020.00

Open Price	1280.00
High Price	1289.80
Low Price	1278.10
Last Price	1281.80
Prev Close	1285.60
Change	-3.80
% Change	-0.30 %

Average Price	1284.37
Underlying Value	1275.20
Number of contracts traded	2032
Turnover in Rs. Lakhs	16312
Open Interest	12230000.00
Change in O I	-235630.00
% Change in O I	-1.89 %

Today

|

1W

|

1M

|

1Y

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	246
Price	1275.20

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	625
Price	1282

Quantity	625
Price	1283.5

Holding Details

Latest Corporate Events

Bonus

1 : 1

28-Aug-06

Book Closure

17-Jul-24

19-Jul-24

Dividend

800 %

10-Jul-25

Company News

28-11-2025

Dr. Reddy’s Laboratories ...

24-11-2025

Dr. Reddy’s Laboratories ...

10-11-2025

Clarification sought fro...

24-10-2025

Dr Reddy's Laboratories r...

23-10-2025

Dr. Reddy's gets EIR for ...

16-10-2025

Dr Reddys Laboratories in...

13-10-2025

Dr. Reddy's Lab’s arm rec...

Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores

Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.